News und Analysen
Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
Agilent Technologies Inc. (NYSE: A) today released the company’s annual ESG report, showcasing a comprehensive and growing set of sustainable solutions that enable hundreds of thousands of labs
Is UnitedHealth Group Stock a Millionaire Maker?
Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Few industries are more essential than healthcare. That makes it an excellent place to look for stocks that can perform well over extended periods since the basic services they offer are unlikely to
3 Reasons to Buy Rivian Now
There are plenty of reasons to be pessimistic about the electric vehicle (EV) industry now, but that could also make it a perfect time to buy in while stock prices are depressed. To be fair, not
Trust for the National Mall and Humana Bring Pickleball Back to the National Mall for Second Year with an Expanded Footprint
The Trust for the National Mall, Humana (NYSE: HUM), and the Humana Foundation announced today that the National Mall of Pickleball is returning to America’s Front Yard, the National Mall, for a
University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky
The University of Louisville’s College of Business recently released the results of a study that evaluated Humana’s economic and community impact on Kentucky.
This press release features
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it
What Is the Dividend Payout for UnitedHealth Group Stock?
Healthcare giants sometimes pay decent dividend distributions, and UnitedHealth Group (NYSE: UNH) certainly falls into that category. In the wake of difficult circumstances, however, investors might
U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?
On April 19, U.S. Rep. Thomas Kean Jr., R-N.J., bought shares of Illumina (NASDAQ: ILMN) and sold shares of Nike (NYSE: NKE), according to a May 31 filing. Although it's unclear exactly how many
Medtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth Stock
Dividend growth stocks can make for excellent long-term investments. Their ongoing rate increases allow investors to generate more in dividend income than if they were to just invest in a stale
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or
University of Alabama at Birmingham (UAB) Health System and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in Alabama
The University of Alabama at Birmingham (UAB) Health System and Humana, a leading health and well-being company, have signed an in-network agreement, expanding access to care for all Humana
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Every good thing must come to an end -- and, eventually, the bull market we're experiencing will, too. Long-term investors must prepare for that to happen at some point.
One of the best ways to do
Is Medtronic Stock a Buy?
Medtronic (NYSE: MDT) is a top healthcare company and a leading maker of medical devices. At a market cap of more than $100 billion, the business has soundly established itself in the industry. It
Meet the 3 Largest Holdings in Harvard University's Portfolio (Hint: Nvidia Isn't 1 of Them!)
When it comes to college prestige, Ivy League schools often sit at or near the top of the pecking order. In exchange for a small fortune -- as of the 2022-2023 academic year, annual tuition and fees
Medtronic Stock Is a Sell, According to 1 Wall Street Analyst
One week ago, medical device maker Medtronic (NYSE: MDT) surpassed Wall Street's sales and earnings targets. Despite the earnings beat, and despite giving guidance that mostly matched analysts'
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders: all proposals approved
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in CVS Stock.
CVS Health (NYSE: CVS) is one of the most influential healthcare companies in the country.
It operates the nation's largest pharmacy chain, a massive pharmacy benefit management business, and the
Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?
Shares of Medtronic (NYSE: MDT) responded poorly to the company's latest quarterly results announcement. The market knocked the stock about 5% lower on May 23, but some analysts who follow the
Medtronic (MDT) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Medtronic (NYSE: MDT)Q4 2024 Earnings CallMay 23, 2024, 8:00 a.m. ET
Ryan Weispfenning
Source Fool.com
Why Medtronic Stock Slumped Today
Medtronic (NYSE: MDT) stock slipped 2.8% through 10:15 a.m. ET this morning despite beating earnings forecasts in its fiscal Q4 2024 earnings report.
Heading into earnings, analysts had the medical